175:4 N F B Jakobsen and others FHH and cardiovascular health 175:4 299–309 Clinical Study The cardiovascular system in familial hypocalciuric hypercalcemia: a cross- sectional study on physiological effects of inactivating variants in the calcium-sensing receptor gene Niels Frederik Breum Jakobsen1, Esben Laugesen1,2,3, Lars Rolighed4, Peter H Nissen5, Per Løgstrup Poulsen1, Erling Bjerregaard Pedersen3,6, Leif Mosekilde1 and Lars Rejnmark1,3 1Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark, Correspondence 2Danish Diabetes Academy, Odense University Hospital, Odense, Denmark, 3Department of Clinical should be addressed Medicine, Aarhus University, Aarhus, Denmark, 4Departments of Surgery and 5Clinical Biochemistry, to L Rejnmark Aarhus University Hospital, Aarhus, Denmark, and 6University Clinic in Nephrology and Hypertension, Email Holstebro Hospital, Hospital Jutland West, Holstebro, Denmark
[email protected] Abstract Objective: Loss-of-function variants in the gene encoding the calcium-sensing receptor (CASR) result in familial hypocalciuric hypercalcemia (FHH), causing hypercalcemia with high normal or elevated parathyroid hormone levels. The CASR may also influence electrolyte and water homeostasis. It is unknown whether FHH affects cardiovascular health. We, therefore investigated whether FHH is associated with changes in the regulation of the cardiovascular system by measuring 24-h blood pressure (BP), arterial stiffness and vasoactive hormones. European Journal European of Endocrinology Design: Cross-sectional study comparing 50 patients with FHH to age- and gender-matched controls. Results: Studied subjects (69% women) had a mean age of 56 years. A similar number of patients and controls (33%) were on treatment with antihypertensive drugs. Overall, no differences were found between groups in 24-h ambulatory BP or pulse wave velocity.